Trecondyv (treosulfan)

pCPA File Number: 22608

Negotiation Status:

Under consideration for negotiation

Indication(s):

In combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult patients with AML or MDS at increased risk for standard conditioning therapies.

Sponsor/Manufacturer:

Medexus Pharmaceuticals, Inc.

CADTH Project Number:

PC0324-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable